Financial reports
10-K
2023 FY
Annual report
1 Apr 24
10-Q
2023 Q3
Quarterly report
14 Nov 23
10-Q
2023 Q2
Quarterly report
14 Aug 23
10-Q
2023 Q1
Quarterly report
15 May 23
10-K
2022 FY
Annual report
31 Mar 23
10-Q
2022 Q3
Quarterly report
10 Nov 22
10-Q
2022 Q2
Quarterly report
12 Aug 22
10-Q
2022 Q1
Quarterly report
13 May 22
10-K/A
2021 FY
Annual report (amended)
29 Apr 22
Current reports
8-K
Regulation FD Disclosure
12 Apr 24
8-K
Berubicin study enrollment completed; Topline data expected in first half of 2025
1 Apr 24
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
27 Feb 24
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
21 Feb 24
8-K
Entry into a Material Definitive Agreement
2 Feb 24
8-K
Departure of Directors or Certain Officers
23 Jan 24
8-K
Regulation FD Disclosure
21 Dec 23
8-K
CNS Pharmaceuticals Announces Successful Interim Analysis of Efficacy
18 Dec 23
8-K
Results of Operations and Financial Condition
15 Nov 23
8-K
Regulation FD Disclosure
18 Oct 23
Registration and prospectus
424B4
Prospectus supplement with pricing info
31 Jan 24
S-1/A
IPO registration (amended)
22 Jan 24
S-1/A
IPO registration (amended)
10 Jan 24
S-1
IPO registration
8 Dec 23
424B3
Prospectus supplement
30 Nov 23
S-8
Registration of securities for employees
21 Nov 23
S-3
Shelf registration
20 Nov 23
424B4
Prospectus supplement with pricing info
2 Dec 22
S-1/A
IPO registration (amended)
28 Nov 22
S-1/A
IPO registration (amended)
15 Nov 22
Proxies
DEF 14A
Definitive proxy
9 Apr 24
PRE 14A
Preliminary proxy
28 Mar 24
DEF 14A
Definitive proxy
14 Aug 23
DEF 14A
Definitive proxy
7 Jul 22
PRE 14A
Preliminary proxy
24 Jun 22
DEF 14A
Definitive proxy
8 Jun 21
PRE 14A
Preliminary proxy
27 May 21
DEF 14A
Definitive proxy
24 Apr 20
Other
EFFECT
Notice of effectiveness
30 Jan 24
CORRESP
Correspondence with SEC
26 Jan 24
CORRESP
Correspondence with SEC
26 Jan 24
CORRESP
Correspondence with SEC
25 Jan 24
CORRESP
Correspondence with SEC
25 Jan 24
CORRESP
Correspondence with SEC
24 Jan 24
CORRESP
Correspondence with SEC
24 Jan 24
CORRESP
Correspondence with SEC
18 Jan 24
CORRESP
Correspondence with SEC
18 Jan 24
CORRESP
Correspondence with SEC
16 Jan 24